US Stock MarketDetailed Quotes

XRTX XORTX Therapeutics

Watchlist
  • 2.5987
  • +0.0372+1.45%
Close May 2 16:00 ET
7.53MMarket Cap-2384P/E (TTM)

About XORTX Therapeutics Company

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

Company Profile

SymbolXRTX
Company NameXORTX Therapeutics
Listing DateOct 13, 2021
Founded2011
CEODr. Allen Warren Davidoff, PhD
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3710–33rd Street NW
CityCalgary
ProvinceAlberta
CountryCanada
Zip CodeT2L 2M1
Phone1-403-455-7717
Websitehttp://www.xortx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Allen Warren Davidoff, PhD
  • President, Chief Executive Officer and Director
  • 571.48K
  • Dr. Stephen Haworth
  • Chief Medical Officer
  • 344.56K
  • Amar Keshri
  • Chief Financial Officer
  • 246.75K
  • Dr. Stacy Evans
  • Chief Business Officer
  • 115.64K
  • Anthony J. Giovinazzo
  • Non Executive Chairman of the Board
  • 267.78K
  • Jacqueline H.R. Le Saux
  • Independent Director
  • 52.93K
  • William Farley
  • Independent Director
  • 50.13K
  • Paul Joseph Van Damme
  • Independent Director
  • 53.73K
  • Dr. Raymond Pratt
  • Independent Director
  • 48.93K
  • Ian McCulloch Klassen, M.B.A.,P.Eng.
  • Independent Director
  • 52.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg